{"id":"W3119648922","doi":"10.1101/2021.01.07.21249390","title":"Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19 – Preliminary report","year":2021,"lang":"en","type":"preprint","venue":"medRxiv","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":137,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Manitoba; Université Laval; University of Alberta; University Health Network; University of Toronto; University of British Columbia; Université de Sherbrooke; St. Michael's Hospital","funders":"FP7 Health; NIHR Imperial Biomedical Research Centre; Health Research Council of New Zealand; Minderoo Foundation; Department of Health and Social Care; National Institute for Health and Care Research; Health Research Board; Medical Research Council; Breast Cancer Research Foundation; European Commission; Sanofi; Wellcome Trust; National Health and Medical Research Council","keywords":"Tocilizumab; Medicine; Interquartile range; Internal medicine; Intensive care unit; Odds ratio; Randomized controlled trial; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002724609,0.0002904792,0.0007757291,0.0001179066,0.0001761501,0.0006122549,0.0002292434,0.0005226426,0.001283413],"category_scores_gemma":[0.004355102,0.00009237284,0.0007164911,0.0002493754,0.0002144683,0.0003190335,0.0002320963,0.0009075138,0.0001819838],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000297293,"about_ca_system_score_gemma":0.0005353711,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003488561,"about_ca_topic_score_gemma":0.0004022123,"domain_scores_codex":[0.9987757,0.0007028701,0.0001924232,0.0001190395,0.0001184755,0.00009149873],"domain_scores_gemma":[0.9967084,0.001680015,0.0007561654,0.0001669532,0.0003823995,0.0003061671],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.4150758,0.004371345,0.2889911,0.005402041,0.003952065,0.004020017,0.0003121091,0.001874479,0.02220163,0.0009520403,0.007580352,0.245267],"study_design_scores_gemma":[0.09832269,0.2864467,0.5286829,0.002180719,0.008279729,0.009676231,0.0004165894,0.005040283,0.01528311,0.001201859,0.04429711,0.0001720882],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9479511,0.04280948,0.001834703,0.001900352,0.0003507551,0.0006617316,0.001177507,0.00002694096,0.003287362],"genre_scores_gemma":[0.990842,0.004966262,0.0009479588,0.0007563754,0.0006828005,0.0002790681,0.00122122,0.000005499075,0.000298733],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002724609,"threshold_uncertainty_score":0.01440924,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04468168577270613,"score_gpt":0.406965089912327,"score_spread":0.3622834041396208,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}